ConductScience.org, home

Paper1382014

Drug treatment of the irritable bowel syndrome.

Pattee PL and 1 other. Drugs, 1992. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Drug treatment of the irritable bowel syndrome. Papers, record 1382014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1382014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug treatment of the irritable bowel syndrome.
PubMed
Journal
Drugs
PubMed
Year
1992
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.45
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pattee PLP L
2Thompson WGW G

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colonic Diseases, FunctionalMajor topic
Analgesics
Antidepressive Agents
Constipation
Diarrhea
Female
Gastrointestinal Agents
Humans
Male
Pain
Parasympatholytics
Physician-Patient Relations
Placebo Effect

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114022607The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation.Gut1962https://conductscience.org/library/papers/14022607PubMed
25446971Irritable colon syndrome.J Indian Med Assoc1970https://conductscience.org/library/papers/5446971PubMed
36365490Role of loperamide and placebo in management of irritable bowel syndrome (IBS).Dig Dis Sci1984https://conductscience.org/library/papers/6365490PubMed
44554271Mebeverine, an effective agent in the irritable colon syndrome.Aust N Z J Med1972https://conductscience.org/library/papers/4554271PubMed
57369370Effect of dietary components on gastrocolonic response.Am J Physiol1980https://conductscience.org/library/papers/7369370PubMed
61586090The irritable bowel syndrome: review and a graduated multicomponent treatment approach.Ann Intern Med1992https://conductscience.org/library/papers/1586090PubMed
770639Wheat fibre and irritable bowel syndrome. A controlled trial.Lancet1977https://conductscience.org/library/papers/70639PubMed
83755416Alternative medicine consultations and remedies in patients with the irritable bowel syndrome.Gut1986https://conductscience.org/library/papers/3755416PubMed
96106097Site of pain from the irritable bowel.Lancet1980https://conductscience.org/library/papers/6106097PubMed
106136745Controlled study of psychotherapy in irritable bowel syndrome.Lancet1983https://conductscience.org/library/papers/6136745PubMed
11765183Colonic myoelectric activity in the irritable bowel syndrome.Gastroenterology1976https://conductscience.org/library/papers/765183PubMed
123286362Controlled treatment trials in the irritable bowel syndrome: a critique.Gastroenterology1988https://conductscience.org/library/papers/3286362PubMed
133948628Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.Dig Dis Sci1986https://conductscience.org/library/papers/3948628PubMed
147188174Irritable bowel syndrome.Ceylon Med J1982https://conductscience.org/library/papers/7188174PubMed
153004197A strategy for management of the irritable bowel.Am J Gastroenterol1986https://conductscience.org/library/papers/3004197PubMed
166843184Irritable bowel syndrome. Role of lactase deficiency.Mayo Clin Proc1983https://conductscience.org/library/papers/6843184PubMed
173081078Pseudo food allergy.Br Med J (Clin Res Ed)1986https://conductscience.org/library/papers/3081078PubMed
183030904Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.Gut1987https://conductscience.org/library/papers/3030904PubMed
196988198Laxatives: clinical pharmacology and rational use.Drugs1980https://conductscience.org/library/papers/6988198PubMed
202865504The irritable bowel syndrome: a paroxysmal motor disorder.Lancet1985https://conductscience.org/library/papers/2865504PubMed

See all 42 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
41948519Efficacy and safety of non-invasive transcutaneous nerve stimulation in patients with irritable bowel syndrome: a systematic review and meta-analysis.Ther Adv Gastroenterol2026https://conductscience.org/library/papers/41948519PubMed
16874854Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.World J Gastroenterol2006https://conductscience.org/library/papers/16874854PubMed
7899232Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.Pharm Res1994https://conductscience.org/library/papers/7899232PubMed
7587797Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study.Dig Dis Sci1995https://conductscience.org/library/papers/7587797PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1382014

GET https://conductscience.org/api/papers/v1/1382014/references?page=2